Cargando…

Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions

Detalles Bibliográficos
Autor principal:	Sabapathy, Kanaga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047636/ https://www.ncbi.nlm.nih.gov/pubmed/33869070 http://dx.doi.org/10.3389/fonc.2021.665504

Ejemplares similares

The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2015)

Corrigendum to ‘Understanding p53 functions through p53 antibodies’
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Understanding p53 functions through p53 antibodies
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

Cancer Cells Shuttle Extracellular Vesicles Containing Oncogenic Mutant p53 Proteins to the Tumor Microenvironment
por: Bhatta, Bibek, et al.
Publicado: (2021)

Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015)

Amplifying Tumor–Stroma Communication: An Emerging Oncogenic Function of Mutant p53
por: Capaci, Valeria, et al.
Publicado: (2021)

Cancer therapeutic targeting using mutant–p53-specific siRNAs
por: Ubby, Ifeoma, et al.
Publicado: (2019)

Beyond the Mevalonate Pathway: Control of Post-Prenylation Processing by Mutant p53
por: Borini Etichetti, Carla M, et al.
Publicado: (2020)

Rab11-FIP1/RCP Functions as a Major Signalling Hub in the Oncogenic Roles of Mutant p53 in Cancer
por: von Grabowiecki, Yannick, et al.
Publicado: (2021)

Editorial: Overcoming the cell membrane to target intracellular oncoproteins
por: Brown, Christopher J., et al.
Publicado: (2023)

Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants
por: Yang, Lu, et al.
Publicado: (2021)

p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?
por: Wang, Chao, et al.
Publicado: (2020)

Regulation of Mutant p53 Protein Expression
por: Vijayakumaran, Reshma, et al.
Publicado: (2015)

Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile
por: Brown, Kate, et al.
Publicado: (2023)

Mutant p53 as a Regulator and Target of Autophagy
por: Shi, Yong, et al.
Publicado: (2021)

Mutant p53 in Cancer Progression and Targeted Therapies
por: Zhu, Gaoyang, et al.
Publicado: (2020)

Aids to Poor Sufferers: Some Invalid Contrivances
Publicado: (1906)

A Contrivance for the Ready Handling of Disabled Horses
por: Griffith, Frederick
Publicado: (1902)

Oncogenic Intra-p53 Family Member Interactions in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2016)

p73: a Positive or Negative Regulator of Angiogenesis, or Both?
por: Sabapathy, Kanaga
Publicado: (2016)

Alterations in Mitochondrial and Endoplasmic Reticulum Signaling by p53 Mutants
por: Giorgi, Carlotta, et al.
Publicado: (2016)

Mutant p53 and ETS2, a Tale of Reciprocity
por: Martinez, Luis Alfonso
Publicado: (2016)

Mutant p53: One, No One, and One Hundred Thousand
por: Walerych, Dawid, et al.
Publicado: (2015)

Mutant p53 exerts oncogenic functions by modulating cancer cell metabolism
por: Zhou, Ge, et al.
Publicado: (2014)

Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
por: Pedrote, Murilo M., et al.
Publicado: (2020)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Editorial: Mutant p53 in Cancer Progression and Personalized Therapeutic Treatments
por: Timofeev, Oleg
Publicado: (2021)

Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer
por: Kim, Michael Paul, et al.
Publicado: (2015)

Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
por: Schmidt, Valentina, et al.
Publicado: (2017)

Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin
por: Therachiyil, Lubna, et al.
Publicado: (2020)

Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
por: Haupt, Sue, et al.
Publicado: (2016)

Behavioral Fatigue: Real Phenomenon, Naïve Construct, or Policy Contrivance?
por: Harvey, Nigel
Publicado: (2020)

Phytoremediation of Heavy Metals: An Indispensable Contrivance in Green Remediation Technology
por: Sabreena,, et al.
Publicado: (2022)

Wiring the oncogenic circuitry: Pin1 unleashes mutant p53
por: Napoli, Marco, et al.
Publicado: (2011)

The rebel angel: mutant p53 as the driving oncogene in breast cancer
por: Walerych, Dawid, et al.
Publicado: (2012)

Editorial: Human Tumor-Derived p53 Mutants: A Growing Family of Oncoproteins
por: Haupt, Ygal, et al.
Publicado: (2016)

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
por: Chasov, Vitaly, et al.
Publicado: (2020)

Characterization of Novel and Uncharacterized p53 SNPs in the Chinese Population – Intron 2 SNP Co-Segregates with the Common Codon 72 Polymorphism
por: Phang, Beng Hooi, et al.
Publicado: (2011)

The Mutant p53-Driven Secretome Has Oncogenic Functions in Pancreatic Ductal Adenocarcinoma Cells
por: Butera, Giovanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dqh8j23bq7k4kc9p5lp6gkcpgc